基础医学与临床 ›› 2018, Vol. 38 ›› Issue (9): 1280-1285.

• 研究论文 • 上一篇    下一篇

miR-185在妊娠合并系统性红斑狼疮患者的T细胞异常甲基化中的作用及分子机制

刘恩令1,刘铮2,周玉秀3,张冬红1,陈梅1   

  1. 1. 河北医科大学附属唐山市工人医院妇产科
    2. 天津医科大学总医院风湿科
    3. 河北医科大学附属唐山市工人医院风湿科
  • 收稿日期:2017-12-01 修回日期:2018-06-04 出版日期:2018-09-05 发布日期:2018-09-10
  • 通讯作者: 刘恩令 E-mail:enling111@sina.com
  • 基金资助:
    河北省科技厅项目

Role and molecular mechanism of miR-185 in aberrant methylation of T cells in pregnancy patients with systemic lupus erythematosus

  • Received:2017-12-01 Revised:2018-06-04 Online:2018-09-05 Published:2018-09-10

摘要: 目的 探讨miR-185是否在妊娠合并系统性红斑狼疮(SLE)患者中有重要作用。方法 采用实时定量PCR和蛋白质印迹分析等分子生物学技术对miR-185在SLE患者的T细胞异常甲基化中所起的作用进行研究,并与健康人群对比,分析其可能的分子机制。 结果 miR-185在妊娠合并SLE患者的CD4+ T细胞中显著上调,其过表达与DNA甲基转移酶1(DNMT1)mRNA水平呈负相关。miR-185靶基因预测分析和双荧光素酶报告实验结果证实,DNMT1是miR-185的直接作用靶标。而且,在健康人CD4+ T细胞中,miR-185的过表达会导致DNA低甲基化和CD11a和CD70基因编码的上调。抑制SLE患者的CD4+ T细胞中miR-185的表达,会产生DNA甲基化逆转作用。结论 miR-185通过靶向作用于DNMT1导致系统性红斑狼疮患者妊娠期间CD4+ T细胞的DNA低甲基化。因此,miR-185可能是SLE干预治疗的潜在治疗靶点。

关键词: 系统性红斑狼疮, 妊娠, CD4+ T细胞, miR-185, 低甲基化, 分子机制

Abstract: Objective To investigate whethermiR-185 plays a role in the pregnancy associated with SLE. Methods Real time PCR and Western blot analysis were used to investigate the role of miR-185 in aberrant methylation of T cells in SLE patients and analyze its molecular mechanism by comparing with healthy populations. Results The results revealed that miR-185 was significantly upregulated in CD4+ T cells from patients with pregnancy complicated with SLE and its degree of over-expression was inversely correlated with DNA methyltransferase 1 (DNMT1) mRNA levels. Target gene of miR-185 prediction analysis and dualluciferase reporter assays confirmed that DNMT1 was a direct target of miR-185. Furthermore, over-expression of miR-185 in CD4+ T cells from healthy donors led to the DNA hypo-methylation and up-regulation of genes encodingCD11a and CD70. Inhibition of miR-185 expression in CD4+ T cells from patients with SLE caused revers effects. Conclusions This study indicated that miR-185 contributes to DNA hypo-methylation of CD4+ T cells in pregnancy patients with systemic lupus erythematosus by targeting DNA methyltransferase 1. Thus, miR-185 may represent apotential therapeutic target for SLE intervention.

Key words: Systemic lupus erythematosus, Pregnancy, miR-185, CD4+ T, Hypomethylation , Molecular Mechanisms